Literature DB >> 7511081

T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping.

S Plaeger-Marshall1, V Isacescu, S O'Rourke, J Bertolli, Y J Bryson, E R Stiehm.   

Abstract

Immune activation is an important component of HIV disease in adults that may reflect a protective host response and/or be a component of immunopathogenesis. The goals of this study were to gain understanding of T cell activation in pediatric HIV disease, to assess the usefulness of T cell activation markers as surrogates for disease progression and/or early identification of infection in infants at risk, and to determine any advantages of three- compared to two-color flow cytometric immunophenotyping for the above assessments. We examined the expression of cell-surface activation antigens on the CD4 and CD8 T cells of 26 HIV-infected and 40 HIV-seronegative age-matched control children. Compared with controls, HIV-infected children showed a slight but not significant decrease in the proportion of CD4 cells that coexpressed CD45RA and L-selectin (mean of 83 vs 75% for < 2 years of age, 76 vs 62% for 2-3 years, 64 vs 56% for > or = 4 years). CD4 cells coexpressing CD38 and HLA-DR were significantly increased in HIV+ children (mean of 2 vs 6% for < 2 years of age, 3 vs 11% for 2-3 years, 2 vs 8% for > or = 4 years). There was a striking and significant increase in the proportion of CD8 cells coexpressing CD38 and HLA-DR (mean of 5 vs. 25% for < 2 years, 10 vs 41% for 2-3 years, 6 vs 31% for > or = 4 years); this double positive population of CD8 cells included cells that were approximately 1 log brighter for the expression of CD38 than for that of CD38 single-positive cells. There was a significant reduction in CD45RA+ CD8 cells (means of 92 vs 71% for < 2 years of age, 88 vs 50% for 2-3 years, 80 vs 57% for > or = 4 years) and an increase in CD57+ CD8 cells (mean of 4 vs 8% for < 2 years of age, 8 vs 22% for 2-3 years, 19 vs 31% for > or = 4 years) in HIV+ children. The inclusion of CD3 as an anchor marker for CD8 cell subsets to limit the analysis to CD3+ CD8 cells did not substantially alter the data nor enhance the differences between infected and control children compared with the analysis of all CD8 cells.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511081     DOI: 10.1006/clin.1994.1046

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  13 in total

1.  Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers.

Authors:  K C Rich; J N Siegel; C Jennings; R J Rydman; A L Landay
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

2.  Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.

Authors:  S Resino; J Navarro; J M Bellón; D Gurbindo; J A León; M A Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

3.  Correlation of immune activation during late pregnancy and early postpartum with increases in plasma HIV RNA, CD4/CD8 T cells, and serum activation markers.

Authors:  Hong-Ha M Truong; Myung S Sim; Maryanne Dillon; Christel H Uittenbogaart; Ruth Dickover; Susan F Plaeger; Yvonne J Bryson
Journal:  Clin Vaccine Immunol       Date:  2010-10-27

4.  Timing of lymphocyte activation in neonates infected with human immunodeficiency virus.

Authors:  K Gallagher; M Gorre; N Harawa; M Dillon; D Wafer; E R Stiehm; Y Bryson; D Song; R Dickover; S Plaeger
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

5.  The Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from Uganda.

Authors:  Isaac Ssewanyana; Chris A R Baker; Theodore Ruel; Stephanie Bousheri; Moses Kamya; Grant Dorsey; Philip J Rosenthal; Edwin Charlebois; Diane Havlir; Huyen Cao
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

6.  HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjects.

Authors:  Emmanouil Papasavvas; Elizabeth C Moore; Junwei Sun; Livio Azzoni; Maxwell Pistilli; Karam Mounzer; Jane Shull; Jay R Kostman; Luis J Montaner
Journal:  AIDS Res Hum Retroviruses       Date:  2008-09       Impact factor: 2.205

7.  Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.

Authors:  S Resino; M L Abad; J Navarro; J M Bellón; S Sánchez-Ramón; M Angeles Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

8.  Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children.

Authors:  Salvador Resino; Isabel Galán; José M Bellón; M Luisa Navarro; Juan Antonio León; M Angeles Muñoz-Fernandez
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

9.  Preserved immune system in long-term asymptomatic vertically HIV-1 infected children.

Authors:  S Resino; R Correa; J M Bellón; M A Muñoz-Fernández
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

10.  Expression of adhesion molecules and CD28 on T lymphocytes during human immunodeficiency virus infection.

Authors:  S W Park; W Royal; R D Semba; G W Wiegand; D E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  1998-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.